Stay updated with breaking news from Jonathan Steckbeck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Atul Deshpande, Ph.D., MBA, A-PMP, appointed Chief Strategy Officer at Peptilogics– Nicholas Pachuda, DPM, promoted to Chief Operating Officer at PeptilogicsPITTSBURGH--(BUSINESS WIRE)--Peptilogics, a clinical stage biotech company engineering peptide therapeutic solutions for patients with life-threatening diseas...
PITTSBURGH, Jan. 26, 2022 -- Peptilogics, a biotech company that designs peptide therapeutics, today announced that it has promoted Nicholas "Nick"
Peptilogics Strengthens Leadership Team with Three Strategic Appointments - Dr. David Huang, leader in anti-infective drug development, to serve as SVP, Chief Medical Officer - Dr. Nick Nystrom, global leader in life sciences AI, to serve as SVP, Computing & Data - Nicholas Pachuda, seasoned expert in business strategy, to serve as SVP, Portfolio Strategy & Development News provided by Share this article Share this article PITTSBURGH, March 17, 2021 /PRNewswire/ -- Peptilogics, a biotechnology platform company leveraging computational design to discover novel peptide therapeutics, announces ...
Peptilogics, a Pittsburgh, PA-based clinical-stage biotechnology company, closed a $35.4m Series B financing. The round was led by Presight Capital, with participation from a new investor syndicate including Founders Fund as well as from existing investor Peter Thiel. The company intends to use the funds to expand its computational platform and invest in technologies to improve its drug design engine, as well as accelerate development of a pipeline of peptide therapeutics including the lead clinical asset, PLG0206, which has demonstrated first-in-class safety and best-in-class efficacy....